Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


New Horizons In Medical Imaging: An Interview With Siemens’ Gregory Sorensen

Medtech Insight interviews Gregory Sorensen, MD, CEO of Siemens Healthcare, North America

Executive Summary

Marketplace uncertainty and pressures to reduce costs have had a major impact on the market for medical imaging technologies. Medtech Insight interviews Gregory Sorensen, MD, Siemens Healthcare’s CEO for North America about what’s on the horizon for the industry.

You may also be interested in...

Radiology Experts Debate How To Convey Radiation Exposure Risks To Patients, Physicians

Prominent radiologists and researchers discussed how best to convey risks associated with medical imaging at a Dec. 8-9 meeting in Washington, D.C.

Siemens To Launch PET/MRI Combo This Summer Following 510(k) Clearance

Siemens will begin shipments this summer of its Biograph mMR system, the first device to simultaneously perform full-body PET and MRI scans, following receipt of 510(k) clearance on June 10.

Alzheimer's Dx: An Essential Piece of the Puzzle

Finding growth opportunities in an era of constrained spending and health care reform is not an easy task, but an increasing number of companies operating in the diagnostics space are taking aim at one underserved area they believe will be a big winner in the years ahead: Alzheimer’s disease. This is a field still in its infancy and the risk of failure remains high. But as research progresses, it’s becoming clear that advances in AD diagnostics could play a major role in reducing that risk.


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts